The use of cannabis among older adults is increasing in the United States. While cannabis use has been suggested to help alleviate chronic symptoms experienced by older adults, its potential adverse effects may lead to unintended consequences, including increased acute healthcare utilization related to its use. This GSA Policy Profile delves into what has happened in the environment since 2021 when GSA published Medical Use of Cannabidiol in Older Adults, which was based on a convening of experts in pharmacy, clinical medicine, research, law, and policy.

Additional resources:

Common Terminology & Glossary (April 2023 Version)

Cannabis Infographic


FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)

Guests:
Libby Baney, J.D., Partner, Faegre Drinker Biddle & Reath LLP
Carmen Witsken, PharmD, Executive Fellow in Association Leadership and Management at American Society of Consultant Pharmacists

Host:

Patricia M. "Trish" D'Antonio, BSPharm, MS, MBA, BCGP, Vice President, Policy and Professional Affairs, The Gerontological Society of America.

This podcast episode is supported by Jazz Pharmaceuticals